WESTFORD, Mass., April 3, 2013 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced the presentation of 16 scientific abstracts at LASER 2013, the 33 rd Annual Scientific Conference of the American Society for Laser Medicine and Surgery (ASLMS). The clinical research includes four abstracts intended to demonstrate the safety and efficacy of the Company's PicoSure picosecond Alexandrite laser technology for aesthetic indications including the removal of tattoos and the improvement of acne scarring and stretch marks. LASER 2013 takes place April 3-7, 2013 at the Sheraton Boston Hotel/Hynes Convention Center in Boston, Massachusetts. "The PicoSure data being presented at LASER 2013 underscores the clinical benefits of the technology for patients seeking a safe, effective treatment with minimal downtime," said Michael Davin, Cynosure's Chairman and Chief Executive Officer. "Quite simply, PicoSure produced better results with fewer treatments than current modalities, with high levels of patient and physician satisfaction." PicoSure is the industry's first picosecond laser cleared for the removal of tattoos and benign pigmented lesions. The device received 510(k) clearance from the U.S. Food and Drug Administration at the end of 2012. Cynosure is currently launching PicoSure in the United States. Unlike longer pulse energy sources whose principal mechanism of action is photothermal or heat-producing, a picosecond laser delivers photothermal and significant photomechanical or acoustic effects. A picosecond laser's pulse is approximately 100 times shorter than the pulse of established treatment modalities, enabling it to treat a range of aesthetic indications with less collateral tissue heating. Key ASLMS Abstracts on PicoSure Kenneth A. Arndt, M.D., Jeffrey S. Dover, M.D. and colleagues at SkinCare Physicians in Chestnut Hill, Mass. led a study that focused on the safety and efficacy of the picosecond Alexandrite 755nm laser for achieving significant pigment clearance in the removal of tattoos. A total of 20 subjects were enrolled in the study. Subjects were allowed up to 10 treatments, and follow-up was conducted from one to three months after the last treatment. "Within three to five treatments, 16 of the 23 tattoos assessed had greater than 75 percent clearance, while 5 had clearance of 51 to 74 percent," the investigators reported. "Our research demonstrated that the PicoSure is not only a safe and highly effective treatment for tattoos, but also clears 50% more rapidly than nanosecond pulsed Q-switched lasers, for years the gold standard for tattoo removal. What differentiates the picosecond laser is its shorter pulse duration, which allows the device to break down and clear the ink particles more quickly."